ClinicalTrials.gg
Sign In

Genetic Predisposition to Disease clinical trials

The registry lists 241 studies for Genetic Predisposition to Disease across more than 10 countries. 95 are recruiting or about to start. 79 of them are mainly about Genetic Predisposition to Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Genetic Risk Score too: 286 studies, 124 open.

Get an email when these change. Save the Genetic Predisposition to Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
95
Recruiting
71
Status unknown
23
Active, not recruiting
18
Not yet recruiting
12
Enrolling by invitation
12

Phase

Phase 1
4
Phase 2
3
Phase 3
2
Phase 4
2

Where

United States
86
Italy
21
France
21
Germany
16
United Kingdom
14
China
11

Who runs them

University Hospital Tuebingen (10) · National Institute of Environmental Health Sciences (NIEHS) (7) · Brigham and Women's Hospital (6) · Abramson Cancer Center at Penn Medicine (6) · St. Jude Children's Research Hospital (6) · The University of Hong Kong (5) · Mayo Clinic (5) · National Cancer Institute (NCI) (4)

What is being tested here

Drugs under test in Genetic Predisposition to Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sirolimus102
Avexitide101
Semaglutide101
Minoxidil101
Trihexyphenidyl101
Cephalexin101
Posaconazole101
Fluconazole101
GLP-1 Mimetic101
Torsemide011

Coming up

0phase 3 studies under way
22studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 71 Genetic Predisposition to Disease studies recruiting now, 36 (51%) set no upper age limit and 28 (39%) stop at 75 or younger. 25 (35%) take children under 18. 9 (13%) are for women only and 5 (7%) for men only; 23 (32%) take healthy volunteers.

Recruiting studies that take each age, of 71
AgeWomenMen
1024 (34%)22 (31%)
1850 (70%)47 (66%)
3049 (69%)45 (63%)
4048 (68%)46 (65%)
5052 (73%)49 (69%)
6551 (72%)48 (68%)
7542 (59%)40 (56%)
8539 (55%)37 (52%)

Across all 241 studies, recruiting or not: 36% stop at 75 or younger and 24% at 65; 30% take children; 11% are for women only and 6% for men only; 41% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Genetic Predisposition to Disease studies take

Of 82 observational studies under Genetic Predisposition to Disease, half reached primary completion within 96 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo18–128 · 57 studies—36 mo18–128 · 57 studies
Observational96 mo52–… · 82 studies—96 mo52–… · 80 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 241. Browse all 241 → or search them.